PLAY PODCASTS
217. The Harms of SSRI's During Pregnancy Debate w/ Dr. Adam Urato and Dr. Robert Chen

217. The Harms of SSRI's During Pregnancy Debate w/ Dr. Adam Urato and Dr. Robert Chen

Radically Genuine Podcast with Dr. Roger McFillin

January 29, 20261h 47m

Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Three facts are scientifically undisputed: Serotonin is essential for fetal brain development. SSRIs disrupt the serotonin system. SSRIs freely cross the placenta. So why are pregnant women being told these drugs carry "little or no risk"?

In this rare head-to-head debate, Dr. Adam Urato—maternal-fetal medicine specialist and FDA expert panelist—faces off against Dr. Robert Chen, a psychiatry resident willing to do what most of his colleagues won't: step into the arena and defend the establishment position.

What unfolds is a striking conversation where both physicians actually agree on more than you'd expect—including that informed consent is failing pregnant women, that the chemical imbalance theory is dead, and that "untreated depression" is a misleading frame designed to sell drugs. The uncomfortable question neither side can fully answer: If SSRIs are correcting depression, why does the research show worse outcomes for women who stay on them?

This isn't anti-medication propaganda. It's the conversation your doctor isn't trained to have with you.

Listen before you fill that prescription.


Visit Center for Integrated Behavioral Health
Dr. Roger McFillin / Radically Genuine Website

YouTube @RadicallyGenuine

Dr. Roger McFillin (@DrMcFillin) / X

Substack | Radically Genuine | Dr. Roger McFillin

Instagram @radicallygenuine


Contact Radically Genuine


Conscious Clinician Collective


PLEASE SUPPORT OUR PARTNERS

15% Off Pure Spectrum CBD (Code: RadicallyGenuine)
10% off Lovetuner click here

Topics

SSRIspregnancyantidepressantsfetal developmentinformed consentmaternal healthdepressionserotoninbirth defectspreterm birthFDApsychiatrypostpartum depressionpharmaceutical industrymental healthZoloftProzacpregnant womenfetal brain developmentmedication risksOBGYNmaternal-fetal medicineplacentanewborn complicationswithdrawalchemical imbalancepsychotherapyperinatal psychiatryACOGevidence-based medicinedrug safetyprenatal caremiscarriageAPGAR scoresNICUneurodevelopmentautismprescription drugsmedical informed consentwomen's health